Page 108 - 《中国药房》2024年22期
P. 108

2022,102(42):3338-3348.                            (2010-10-10) [2023-12-01]. http://www.sign.ac.uk.
               The  National  Pulmonary  Embolism  and  Deep  Venous   [25]  赵纪春,邱贵兴,裴福兴,等. 骨科大手术加速康复围手
               Thrombosis  Prevention  and  Control  Capa-city  Building   术期静脉血栓栓塞症防治专家共识[J]. 中华骨与关节外
               Project Expert Committee,Expert Group Responsible for   科杂志,2022,15(10):754-762.
               Drafting  the  Guidelines  for  Quality  Evaluation  and  Ma-  ZHAO J C,QIU G X,PEI F X,et al. Expert consensus on
               nagement of Prevention and Treatment of Venous Thrombo‐  the  prevention  and  treatment  of  perioperative  venous
               embolism  in  Hospitals (2022  edition).  Guidelines  for   thromboembolism  in  major  orthopaedic  surgery  in  en‐
               quality  evaluation  and  management  of  prevention  and   hanced recovery after surgery program[J]. Chin J Bone Jt
               treatment of venous thromboembolism in hospitals:2022   Surg,2022,15(10):754-762.
               edition[J]. Natl Med J China,2022,102(42):3338-3348.  [26]  TOMKOWSKI W,KUCA P,URBANEK T,et al. Venous
          [17]  王乔宇,武明芬,柳鑫,等. 2021中国静脉血栓栓塞症防                       thromboembolism:recommendations  on  the  prevention,
               治抗凝药物的选用与药学监护指南[J]. 中国临床药理学                         diagnostic  approach  and  management:the  2017  Polish
               杂志,2021,37(21):2999-3016.                           consensus statement[J]. Acta Angiol,2017,23:35-71.
               WANG Q Y,WU M F,LIU X,et al. Guidelines for the se‐  [27]  杨婕,温华,马冰,等. 7种新型口服抗凝药预防全髋、膝
               lection and pharmaceutical care of anticoagulants for the   关节置换术后静脉血栓栓塞症的网状 Meta 分析[J]. 药
               prevention  and  treatment  of  venous  thromboembolism  in   学实践杂志,2018,36(6):541-546.
               China of 2021[J]. Chin J Clin Pharmacol,2021,37(21):  YANG J,WEN H,MA B,et al. Seven kinds of new oral
               2999-3016.                                          anticoagulants for prevention of venous thromboembolism
          [18]  ENCKE A,HAAS S,KOPP I. The prophylaxis of venous   after total hip or knee arthroplasty:a net meta-analysis[J].
               thromboembolism[J].  Dtsch  Arztebl  Int,2016,113(31/  J Pharm Pract,2018,36(6):541-546.
               32):532-538.                                   [28]  HAYKAL T,KHEIRI B,ZAYED Y,et al. Aspirin for ve‐
          [19]  Cardiovascular  Disease  Educational  and  Research Trust,  nous  thromboembolism  prophylaxis  after  hip  or  knee  ar‐
               Cyprus Cardiovascular Disease Educational and Research   throplasty:an  updated  meta-analysis  of  randomized  con‐
               Trust,European Venous Forum,et al. Prevention and treat‐  trolled trials[J]. J Orthop,2019,16(4):312-319.
               ment  of  venous  thromboembolism.  International  consen‐  [29]  MATHARU  G  S,KUNUTSOR  S  K,JUDGE  A,et  al.
               sus statement:guidelines according to scientific evidence  Clinical  effectiveness  and  safety  of  aspirin  for  venous
               [J]. Int Angiol,2006,25(2):101-161.                 thromboembolism prophylaxis after total hip and knee re‐
          [20]  MONT M A,JACOBS J J,BOGGIO L N,et al. Preven-      placement:a systematic review and meta-analysis of ran‐
               ting  venous  thromboembolic  disease  in  patients  under-  domized  clinical  trials[J].  JAMA  Intern  Med,2020,180
               going  elective  hip  and  knee  arthroplasty[J].  J  Am  Acad    (3):376-384.
               Orthop Surg,2011,19(12):768-776.               [30]  KAPOOR A,ELLIS A,SHAFFER N,et al. Comparative
          [21]  SCHÜNEMANN H J,CUSHMAN M,BURNETT A E,et            effectiveness of venous thromboembolism prophylaxis op‐
               al. American Society of Hematology 2018 guidelines for   tions for the patient undergoing total hip and knee replace‐
               management  of  venous  thromboembolism:prophylaxis   ment:a  network  meta-analysis[J].  J  Thromb  Haemost,
               for  hospitalized  and  nonhospitalized  medical  patients[J].   2017,15(2):284-294.
               Blood Adv,2018,2(22):3198-3225.                [31]  HUR M,PARK S K,KOO C H,et al. Comparative effi‐
          [22]  NEUMANN I,IZCOVICH A,AGUILAR R,et al. ASH,         cacy and safety of anticoagulants for prevention of venous
               ABHH,ACHO,Grupo  CAHT,Grupo  CLAHT,SAH,             thromboembolism after hip and knee arthroplasty[J]. Acta
               SBHH,SHU,SOCHIHEM,SOMETH,Sociedad  Pana-            Orthop,2017,88(6):634-641.
               meña de Hematología,SPH,and SVH 2021 guidelines for   [32]  魏志辉,张铭华,赵波,等. 不同剂量利伐沙班与依诺肝
               management of venous thromboembolism in Latin America  素预防全髋关节置换后静脉血栓形成:安全及有效性的
               [J]. Blood Adv,2021,5(15):3032-3046.                Meta 分析[J]. 中国组织工程研究,2016,20(53):8022-
          [23]  ANDERSON D R,MORGANO G P,BENNETT C,et al.          8031.
               American  Society  of  Hematology  2019  guidelines  for   WEI Z H,ZHANG M H,ZHAO B,et al. Different doses
               management  of  venous  thromboembolism:prevention  of   of rivaroxaban versus enoxaparin for prevention of venous
               venous thromboembolism in surgical hospitalized patients  thromboembolism  after  total  hip  arthroplasty:a  meta-
               [J]. Blood Adv,2019,3(23):3898-3944.                analysis of safety and efficacy[J]. Chin J Tissue Eng Res,
          [24]  Scottish  Intercollegiate  Guidelines  Network.  Prevention   2016,20(53):8022-8031.
               and  management  of  venous  thromboembolism[EB/OL].   [33]  LIU  J  C,ZHAO  J  L,YAN  Y,et  al.  Effectiveness  and


          · 2806 ·    China Pharmacy  2024 Vol. 35  No. 22                            中国药房  2024年第35卷第22期
   103   104   105   106   107   108   109   110   111   112   113